PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- First Posted Date
- 2017-02-14
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 296
- Registration Number
- NCT03052608
- Locations
- 🇺🇸
The William P. Beetham Eye Institute, Joslin Diabetes Center, Boston, Massachusetts, United States
🇺🇸Ophthalmic Consultants of Boston Inc, Boston, Massachusetts, United States
🇺🇸University of Washington Medical Center, Seattle, Washington, United States
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2019-07-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 61
- Registration Number
- NCT03041792
- Locations
- 🇺🇸
Translational Research Institute for Metabolism and Diabetes, Orlando, Florida, United States
A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 38
- Registration Number
- NCT03042910
- Locations
- 🇺🇸
UCLA Hematology/Oncology - Porter Ranch, Porter Ranch, California, United States
🇺🇸UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, United States
🇺🇸UCLA Hematology/Oncology - Pasadena, Pasadena, California, United States
Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)
- First Posted Date
- 2017-01-30
- Last Posted Date
- 2023-07-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 449
- Registration Number
- NCT03036813
Sayana Press UK Self-Injection Study
- Conditions
- Contraception
- Interventions
- Drug: Sayana Press
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2019-10-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 169
- Registration Number
- NCT03034057
- Locations
- 🇬🇧
Rame Medical Ltd, Penntorr Health, Torpoint, Cornwall, United Kingdom
🇬🇧Homerton University Hospital NHS Foundation Trust, Homerton, London, United Kingdom
🇬🇧Southport & Ormskirk Hospital NHS Trust, Liverpool, Merseyside, United Kingdom
Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe
- Conditions
- Factor VIII Deficiency, CongenitalAutosomal Hemophilia AHemophilia A, CongenitalFactor 8 Deficiency, CongenitalClassic Hemophilia
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 106
- Registration Number
- NCT03034044
Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
- Conditions
- OsteoarthritisCancer PainRecurrent Low Back Pain
- Interventions
- Drug: Investigational medical product (IMP) administered in parent study
- First Posted Date
- 2017-01-26
- Last Posted Date
- 2021-06-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 4
- Registration Number
- NCT03031938
- Locations
- 🇺🇸
USC Keck School of Medicine, Los Angeles, California, United States
🇺🇸Kennedy and White Orthopaedic Center, Sarasota, Florida, United States
🇺🇸Lafayette Clinical Research Group, Lafayette, Indiana, United States
Multiple Ascending Dose and DDI Study
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2017-01-25
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 62
- Registration Number
- NCT03031119
- Locations
- 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium
Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease
- First Posted Date
- 2017-01-16
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT03021941
- Locations
- 🇺🇸
O&O Alpan LLC, Fairfax, Virginia, United States
Safety and Tolerability of PF-06818883 in Healthy Subjects
- First Posted Date
- 2017-01-13
- Last Posted Date
- 2017-12-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT03020784
- Locations
- 🇺🇸
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States